Salmeterol 50 mg, Fluticasone 250 mg

Salmeterol 50 mg, Fluticasone 250 mg About

INH AIRFLOW 250
Salmeterol (50mg), Fluticasone (250mg)
Salmeterol and fluticasone are two medications often combined in a single inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta2-adrenergic receptor agonist (LABA) that helps to relax the muscles in the airways and make breathing easier. It works by stimulating beta2-receptors in the lungs, which causes the muscles surrounding the airways to relax and the airways to widen. This helps to prevent asthma attacks and improve breathing in individuals with COPD. Salmeterol is used for long-term management and prevention of asthma symptoms and is not intended for the relief of acute symptoms.
Fluticasone is a corticosteroid that reduces inflammation in the airways. It works by inhibiting various inflammatory responses within the lungs, decreasing the swelling and irritation in the airways, and helping to prevent the symptoms of asthma and COPD. As a steroid, it is used for its anti-inflammatory properties and is effective in managing and preventing asthma symptoms when used regularly. Fluticasone is not intended for the relief of sudden breathing problems.

Dual-Action Formula for Effective Relief

This medicine combines Salmeterol (50mg) and Fluticasone (250mg), offering both bronchodilation and anti-inflammatory effects. Such a synergistic approach helps widen the airways while reducing inflammation, making it effective for managing chronic respiratory conditions, including asthma and COPD. The liquid form enhances absorption and ease of use for adult patients.


Proper Storage for Maximum Potency

To maintain the drug's quality and effectiveness, always store it in a cool, dry environment away from direct sunlight. Adhering to recommended storage guidelines ensures that the medicine remains potent and safe throughout its shelf life. A stable, low-humidity setting is highly important for liquid medications.